Guides

Does insurance cover GLP-1 drugs like Wegovy and Zepbound?

GLP-1 coverage depends on the plan and the reason for the prescription: diabetes is usually covered, weight loss often is not. Includes dated Medicare news.

Sometimes. Whether a health plan covers a GLP-1 drug such as Wegovy, Zepbound, Ozempic or Mounjaro depends on two things: which plan you have, and why the drug is prescribed. Plans usually cover these drugs when they are prescribed to treat type 2 diabetes. Coverage for weight loss alone is far less consistent: many employer and individual plans exclude it, some cover it with strict conditions, and Medicare's drug benefit cannot cover a drug used only for weight loss. The only reliable answer for your situation comes from your own plan's drug list and benefit documents.

Why the same drug family is covered differently

GLP-1 drugs (the name comes from a hormone they imitate) are sold under several brand names, and each brand is approved by the Food and Drug Administration (FDA) for specific uses. Ozempic, Rybelsus and Mounjaro are approved for type 2 diabetes. Wegovy and Zepbound are approved for chronic weight management in adults with obesity, or with excess weight and a related condition. Wegovy also has an approved use to reduce the risk of heart attack and stroke in certain adults with heart disease and excess weight, and Zepbound has an approved use for moderate-to-severe obstructive sleep apnea in adults with obesity.

Insurers decide coverage by the approved use, not by the active ingredient. A plan may cover one brand for diabetes and exclude the other brand for weight loss, even though the two are chemically close. That is why a neighbor on a different plan, or on the same plan with a different diagnosis, can tell you something that does not apply to you.

How coverage varies by type of plan

Type of coverage What to expect for diabetes use What to expect for weight-loss use
Employer plan Usually on the drug list, often with prior authorization The employer chooses; many exclude it, some cover it with conditions
Individual or marketplace plan Usually on the drug list Varies by insurer and state; often excluded or restricted
Medicare Part D or Medicare Advantage with drug coverage Generally covered when prescribed for diabetes The law bars Part D from covering drugs used only for weight loss; other approved uses, such as heart risk reduction, can be covered
Medicaid Generally covered Optional for each state; some cover, some do not, and rules change

Two points follow. First, in an employer plan the employer, not only the insurer, sets the benefit, so the question belongs to the benefits office as much as to the insurance company. Second, the individual market follows rules that differ by state, so a plan sold in one state may treat the drug differently from the same insurer's plan in another. Your state marketplace or insurance department can say what the benefit rules are where you live.

The conditions plans commonly attach

Even where a GLP-1 drug is covered, the coverage usually comes with rules. These are common ones:

  • Prior authorization. Your prescriber must send the plan clinical information before the plan agrees to pay.
  • Diagnosis and measurement requirements. The plan may ask for a diagnosis, a recent body mass index (BMI), lab results or both.
  • step therapy. The plan may ask you to try a less expensive drug first, such as metformin for diabetes, and document that it did not work or was not tolerated.
  • Lifestyle program. Some plans for weight-loss coverage require enrollment in a diet, exercise or counseling program.
  • Quantity limits. Plans may cap the amount dispensed per fill and require the pharmacy to use the plan's preferred or specialty pharmacy.
  • Renewal checks. A plan can ask for proof of progress, such as weight change or blood sugar results, before approving a refill period.

Each rule has a written criteria document behind it, which the plan must be able to give you on request. If a request is denied, the denial letter explains the reason and how to appeal.

What changed for Medicare in 2026 and 2027

Three Medicare developments are recorded in federal sources as of November 16, 2026:

  • Medicare GLP-1 Bridge. The Centers for Medicare & Medicaid Services (CMS) launched a bridge program on July 1, 2026. It offers a $50 monthly copay for weight-management GLP-1 drugs to Part D enrollees who are not otherwise covered, and it runs through December 31, 2027. Eligibility and enrollment details are on Medicare.gov and CMS's announcement; check there before assuming you qualify.
  • Negotiated prices. Ozempic, Rybelsus and Wegovy are among the 15 drugs in the second round of Medicare drug price negotiation, and the negotiated prices take effect January 1, 2027. A negotiated price is the price the Medicare program pays; what you pay still depends on your plan's cost sharing.
  • Part D spending cap. Under the standard Part D design, your out-of-pocket spending on covered drugs is capped at $2,100 in 2026 and $2,400 in 2027. The cap applies only to drugs your plan covers, so a drug excluded from your plan does not help you reach it.

Because this area moves quickly, treat any price or program detail you read elsewhere as a dated snapshot. Medicare.gov and the Part D plan's own materials are the current sources. For a fuller explanation of how the benefit works, see Medicare Part D explained: drug plans, formularies and costs.

How to check your own plan

  1. Find the drug list. Search the plan's formulary for the specific brand you were prescribed, not the general class. Note the tier and any codes next to it, such as prior authorization or quantity limit.
  2. Read the exclusions. The plan's evidence of coverage or benefit booklet lists services and drug categories it excludes. Weight-loss drugs, if excluded, usually appear there.
  3. Ask the plan or the benefits office. Ask: Is this drug covered for my diagnosis? Is prior authorization needed? What is my cost at each pharmacy? Does the plan require a specific pharmacy? Ask for the answers in writing or note the date and the representative.
  4. Ask your prescriber's office. Practices often handle prior authorization for GLP-1 drugs every day and know which criteria a plan uses.
  5. Use a worksheet. The doctor, hospital and drug network check worksheet lays out the drug and pharmacy questions to ask before you enroll or renew.

A drug being on the formulary does not mean it is covered for you at a low cost. Check the tier, the deductible and whether the plan's pharmacy network is a factor.

A labeled example of how cost sharing works

Say a hypothetical plan has a $500 drug deductible and charges a 30% coinsurance on a brand-name drug, and the plan's negotiated price for one month of a drug is $1,000 (these are round numbers for illustration, not real prices). In the first month you pay the $500 deductible, then 30% of the remaining $500, which is $150, for a total of $650. In the second month the deductible is met, so you pay 30% of $1,000, or $300. A plan with a flat copay would work differently, and manufacturer savings programs may reduce what you pay on some commercial plans, though your plan may treat that assistance in its own way (see copay accumulators and maximizers: why coupons may not count).

If the plan says no

A denial is not the end of the process. You can ask the prescriber to resubmit with more clinical detail, file an exception or appeal, and in many plans seek an independent review of the decision. Plans exclude weight-loss coverage by design in some cases, and an exclusion is harder to overturn than a denial of a covered drug, but the documents must still say which applies. The steps are in what to do when your plan will not cover a drug you need, and the general workings of approval requests are in how prior authorization works and what to do when it is denied. A state insurance department can say whether a state-regulated plan followed its rules.

Key takeaways

  • Coverage turns on the plan type and the reason for the prescription: diabetes is usually covered, weight loss alone often is not.
  • Medicare Part D cannot cover a drug used only for weight loss, but it can cover other approved uses; the Medicare GLP-1 Bridge ($50 a month, July 1, 2026 through December 31, 2027) is a separate program with its own eligibility.
  • Covered drugs usually come with prior authorization, step therapy, quantity limits or lifestyle requirements, so check the criteria before the first fill.
  • Employer plans set their own benefit, so your benefits office is part of the answer.
  • Prices and program rules change often; confirm with your plan, Medicare.gov or your state marketplace.

Terms used in this guide

Related tools

Latest on this topic